Gut microbiome in Crohn's disease and EEN therapy, China
122 stool samples from Chinese adults and adolescents with Crohn's disease or healthy controls, studying gut microbiota composition and function, including modulation by exclusive enteral nutrition, in a case-control design. machine-written summary
122 samples · 122 runs · CN · Adult · 2016 · 5.40 Gbp / sample
Checked this project's papers and archive records yourself? Mark it human-verified.
what each source gave
| ✓ Sequence archive | 244 sample values (collection date, country) |
| ○ Abstract / description | read; no usable statement |
| ○ Full text | read; no usable statement or table · PMC10131791, PMC11537084, PMC11794259, PMC12891910, PMC13303284, PMC5624284, PMC9506019 |
| ○ Supplementary tables | files read; no table could be matched to the samples |
| ✓ External resources | 506 sample values (age, bmi, health condition, health condition detail, sex) · from curatedMetagenomicData 3 (cMD 3), GMrepo v3 |
| – User contribution | nothing uploaded yet |
| – Human verified | not yet checked by a person · I checked this project — verify it |
intervention — arms not resolved
Controlled / prescribed diet or feeding regimen design single_arm_before_after · population crohns_disease · Exclusive enteral nutrition (EEN) for 2 weeks in CD patients, resampled before/after
“14 of whom were resampled after 2 weeks of EEN” — bioproject.description (study level; per-sample arms are in the intervention column below)
longitudinal — not resolved
Schedule stated by the source: “stool resampled after 2 weeks of exclusive enteral nutrition (EEN) in a subset of CD patients” (time origin: intervention start); stated follow-up 14 d.
Genera, mean relative abundance over 111 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).
| field | samples | coverage | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|
| age_category | 122 | 100% | ||||
| country | 122 | 100% | 122 | |||
| health_condition | 102 | 84% | 102 | |||
| subject_id | 0 | 0% | ||||
| collection_date | 122 | 100% | 122 | |||
| health_condition_detail | 102 | 84% | 102 | |||
| bmi | 101 | 83% | 101 | |||
| sex | 101 | 83% | 101 | |||
| age_at_collection_days | 100 | 82% | 100 |
- Two distinct metacommunities characterize the gut microbiota in Crohn's disease patients. 2017 PMID 28655159 PMC5624284 own_data
- Mesenteric Adipose Tissue-Derived Klebsiella variicola Disrupts Intestinal Barrier and Promotes Colitis by Type VI Secretion System. 2023 PMID 36802200 PMC10131791 own_data
- rRNA operon improves species-level classification of bacteria and microbial community analysis compared to 16S rRNA. 2024 PMID 39365049 PMC11537084 own_data
- Genome analysis of <i>Bifidobacterium adolescentis</i> and investigation of its effects on inflammation and intestinal barrier function. 2024 PMID 39911710 PMC11794259 own_data
- Synergy between Cell Surface Glycosidases and Glycan-Binding Proteins Dictates the Utilization of Specific Beta(1,3)-Glucans by Human Gut Bacteroides. 2020 PMID 32265336 PMC7157763 unsure
32 more
- Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides. 2021 PMID 34061597 PMC8262883
- MetaGeneBank: a standardized database to study deep sequenced metagenomic data from human fecal specimen. 2021 PMID 34592929 PMC8485520
- Diverse events have transferred genes for edible seaweed digestion from marine to human gut bacteria. 2022 PMID 35240043 PMC9096808
- Phage Cocktails Constrain the Growth of Enterococcus. 2022 PMID 35762793 PMC9426582
- Intercontinental Gut Microbiome Variances in IBD. 2022 PMID 36142786 PMC9506019
- Faecal microbiome-based machine learning for multi-class disease diagnosis. 2022 PMID 36357393 PMC9649010
- Microbial genes outperform species and SNVs as diagnostic markers for Crohn's disease on multicohort fecal metagenomes empowered by artificial intelligence. 2023 PMID 37278203 PMC10246480
- Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. 2023 PMID 37932270 PMC10628233
- Enteral nutrition promotes the remission of colitis by gut bacteria-mediated histidine biosynthesis. 2024 PMID 38215690 PMC10827402
- Plasmids in the human gut reveal neutral dispersal and recombination that is overpowered by inflammatory diseases. 2024 PMID 38605009 PMC11009399
- Discovery of disease-adapted bacterial lineages in inflammatory bowel diseases. 2024 PMID 38917808 PMC11239293
- Enhanced microbiota profiling in patients with quiescent Crohn's disease through comparison with paired healthy first-degree relatives. 2024 PMID 38942021 PMC11293350
- Meta-analysis of the human gut microbiome uncovers shared and distinct microbial signatures between diseases. 2024 PMID 39078158 PMC11334437
- The molecular basis of cereal mixed-linkage β-glucan utilization by the human gut bacterium Segatella copri. 2024 PMID 39122003 PMC11418011
- Is There an Interplay between Environmental Factors, Microbiota Imbalance, and Cancer Chemotherapy-Associated Intestinal Mucositis? 2024 PMID 39204125 PMC11357004
- Gut bacterial type III secretion systems aggravate colitis in mice and serve as biomarkers of Crohn's disease. 2024 PMID 39216231 PMC11402190
- Noninvasive, microbiome-based diagnosis of inflammatory bowel disease. 2024 PMID 39367251 PMC11645270
- Oral Microbial Translocation Genes in Gastrointestinal Cancers: Insights from Metagenomic Analysis. 2024 PMID 39458395 PMC11510655
- A meta-analysis of the gut microbiome in inflammatory bowel disease patients identifies disease-associated small molecules. 2025 PMID 39947133 PMC12268991
- Balance between bile acid conjugation and hydrolysis activity can alter outcomes of gut inflammation. 2025 PMID 40210868 PMC11985902
- Improved detection of microbiome-disease associations via population structure-aware generalized linear mixed effects models (microSLAM). 2025 PMID 40424276 PMC12136445
- Constructing inflammatory bowel disease diagnostic models based on k-mer and machine learning. 2025 PMID 40636504 PMC12239758
- Megasphaera Elesdenii Dysregulates Colon Epithelial Homeostasis, Aggravates Colitis-Associated Tumorigenesis. 2025 PMID 40801433 PMC12591162
- Human intestinal fungus Clavispora lusitaniae attenuates colitis through Pyruvate decarboxylase-derived Indole-3-ethanol. 2025 PMID 41233306 PMC12615640
- The gut methanotroph Methylocystis intestini modulates intestinal peristalsis and fat metabolism via reducing methane levels. 2025 PMID 41331251 PMC12764784
- A signature-protein-based approach for accurate and efficient profiling of the human gut virome. 2026 PMID 41365303 PMC12853188
- MetaFX: feature extraction from whole-genome metagenomic sequencing data. 2026 PMID 41557465 PMC12891910
- Microbiota-derived IPA protects against colitis by regulating intestinal HMGCS2-mediated ketogenesis to facilitate mucosal healing. 2026 PMID 41651833 PMC12988232
- A microbiota-IPA axis facilitates intestinal stem cell-mediated regeneration in colitis through a Hopx-associated program. 2026 PMID 41741429 PMC13057028
- Gut Lactate Boosts Ruminococcus via Histone Lactylation to Mediate Time-Restricted Feeding Protection in Crohn's Disease. 2026 PMID 41945859 PMC13271634
- vClassifier: a toolkit for high-resolution phylogenetic classification of prokaryotic viruses. 2026 PMID 42370331 PMC13303284
- Plasmid dispersal and recombination across human gut microbiomes is neutral, but overpowered by inflammatory diseases 2023
Archive description
AbstractBackgroundInflammatory bowel diseases (IBD), with Crohn’s disease (CD) being one of the primary types, have been extensively studied for genetic and gut microbial factors leading to its epidemic in the modern world. However, limited information using metagenomic shotgun-sequencing to pinpoint the gut microbial species and functions involved. Exclusive enteral nutrition (EEN) is a nutritional therapy used for disease-modifying treatment of CD, but its impact on the gut microbiome remains unclear. ResultsWe collected 123 stool samples from 49 CD patients, 14 of whom were resampled after 2 weeks of EEN, and 56 subjects with no disease. Metagenomic shotgun sequencing and analyses confirmed a decreased diversity in the gut microbiota of CD patients, and identified microbial species and potential functions altered in CD, most notably an increased ratio of hexa- to penta-acylated lipopolysaccharide (LPS). Some co-abundance gene groups (CAGs) including Parabacteroides distasonis, Bacteroides intestinalis, Ruminococcus sp. showed strong correlation with clinical indicators such as hs.CRP, Prealbumin, platelets and BMI. The entire cohort could be divided into three types according to their species composition, with Type A largely consisting of healthy controls and Type C containing exclusively CD or after EEN samples. Although compositional changes were generally mild after 2 weeks of EEN, remodeling of the gut microbial network could be observed.ConclusionsOur metagenomic dataset unlock the gut microbiome in CD for functional investigations. Microbiome-based stratification of CD patients before EEN might help optimize the therapy for wider applications.
How this project entered the registry
Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.
- host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
- body site study.title · “The gut microbiome in Crohn's”
- body site study.description · “for genetic and gut microbial factors leading”
- life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
| sample | field | value | route | conf. | source | quote |
|---|---|---|---|---|---|---|
| SAMEA4431868 | age_at_collection_days | 17532.0 | R2 | 0.75 | external.cmd source | age: 48; age_unit: (empty); age_group: Adult |
| SAMEA4431871 | age_at_collection_days | 5844.0 | R2 | 0.75 | external.gmrepo source | host_age: 16.0 |
| SAMEA4431868 | bmi | 22.32 | R2 | 0.75 | external.cmd source | bmi: 22.3183391 |
| SAMEA4431868 | collection_date | 2013 | R1 | 0.90 | biosample.attribute:collection_date | 2013 |
| SAMEA4431868 | country | CN | R1 | 0.90 | sample.attr.geographic_location_country_and_or_sea | China |
| SAMEA4431868 | health_condition | ibd_unspecified | R2 | 0.75 | external.cmd source | disease: Inflammatory Bowel Disease |
| SAMEA4431868 | health_condition_detail | Inflammatory Bowel Disease | R2 | 0.75 | external.cmd source | disease: Inflammatory Bowel Disease |
| SAMEA4431868 | sex | male | R2 | 0.75 | external.cmd source | sex: Male |
Sequencing
122 runs over 122 samples · mean 5.44 Gbp per run (median 5.40 Gbp, total 663.83 Gbp; 122 runs with a base count) · layout PAIRED 122 · platform ILLUMINA 122 · models Illumina HiSeq 2000 (122) · 91% of runs with a Sandpiper profile · first public 2016-11-11
Authors (65)
Pasolli E first · Asnicar F · Manara S · Zolfo M · Karcher N · Armanini F · Beghini F · Manghi P · Tett A · Ghensi P · Collado MC · Rice BL · DuLong C · Morgan XC · Golden CD · Quince C · Huttenhower C · Segata N last · Tarracchini C first · Fontana F · Mancabelli L · Lugli GA · Alessandri G · Turroni F · Ventura M · Milani C last · Xu J first · Li P · Li Z · Liu S · Guo H · Lesser CF · Ke J · Zhao W · Mou X last · Li L first · Liu Z · Qin J · Xiong G · Yang C · Cai F · Huang J last · Wu F first · Wang Y · Mai Z · Xu Z · Li S · Li Y · Yin R · Li J · Yu Z · Wu Y · Tian X · Feng X · Huo X · Wang C · Ma X last · Ivanov A first · Popov V · Morozov M · Olekhnovich E · Ulyantsev V last · Zhou K first · Kosmopoulos JC · Anantharaman K last
Downloads
PRJEB15371.csv.gz (4.5 KB) · parquet (75.5 KB) — all 122 samples, every field with route and confidence · PRJEB15371_determinations.csv.gz (10.0 KB) — 750 evidence rows